Skip Navigation


Carcinogenesis Advance Access originally published online on August 14, 2007
Carcinogenesis 2007 28(12):2624-2631; doi:10.1093/carcin/bgm184
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
28/12/2624    most recent
bgm184v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Cheung, R. S.Y.
Right arrow Articles by Fausto, N.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Cheung, R. S.Y.
Right arrow Articles by Fausto, N.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author 2007. Published by Oxford University Press. All rights reserved. For Permissions, please email: journals.permissions@oxfordjournals.org

Interactions between MYC and transforming growth factor alpha alter the growth and tumorigenicity of liver progenitor cells

Ronald S.Y. Cheung1,2, John T. Brooling1, Melissa M. Johnson1, Kimberly J. Riehle1,3, Jean S. Campbell1 and Nelson Fausto1,*

1 Department of Pathology
2 Molecular and Cellular Biology Graduate Program
3 Department of Surgery, University of Washington, Seattle, WA 98195, USA

* To whom correspondence should be addressed. Tel: +1 206 616 4550; Fax: +1 206 543 3967; Email: nfausto{at}u.washington.edu

The MYC oncogene induces both cell proliferation and apoptosis. The apoptotic function of MYC is thought to inhibit carcinogenesis; thus, when disrupted, tumorigenic potential is increased. Both MYC and transforming growth factor alpha (TGF{alpha}) are commonly over-expressed in hepatocellular carcinomas, and transgenic mice expressing these genes rapidly develop tumors via the suppression of MYC-induced apoptosis by the growth factor. However, the nature of the interactions between MYC and TGF{alpha} are not well understood. Specifically, it is unclear whether TGF{alpha} acts only as an anti-apoptotic factor in its interactions with MYC or whether it has substantial effects on cell growth. We investigated whether TGF{alpha} can provide additional mitogenic signals if it is not required to act as an anti-apoptotic factor. We demonstrate that expression of MYC and TGF{alpha} in liver progenitor cells (known as oval cells) results in enhanced cell proliferation in culture and the generation of poorly differentiated tumors after inoculation into nude mice. We further demonstrate that while the apoptosis-deficient T58A and S71F alleles of MYC retain their ability to promote oval cell proliferation, they have opposite growth interactions with TGF{alpha}. The T58A allele has a stimulatory effect on both proliferation and tumorigenicity. In contrast, co-expression of the S71F allele reduces proliferation and slows tumor development. We conclude that the tumorigenic growth effects of MYC in TGF{alpha}-expressing liver progenitor cells are not solely dependent on its apoptotic activity.

Abbreviations: FACS, fluorescence activated cell sorting; GFP, green fluorescent protein; HCC, hepatocellular carcinoma; MMP, matrix metalloproteinase; PCR, polymerase chain reaction; TACE, TNF-alpha converting enzyme; TGF{alpha}, transforming growth factor alpha; VEGF, vascular endothelial growth factor

Received June 4, 2007; revised July 29, 2007; accepted August 1, 2007.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?




Disclaimer:
Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.